Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
Psychopharmacology
|
February 12, 2013
Impaired cliff avoidance reaction in dopamine transporter knockout mice
Motoyasu Yamashita, Yasufumi Sakakibara, F Scott Hall, et al.
Behavioural Pharmacology
|
February 22, 2014
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Brain Research Bulletin
|
June 3, 2025
Sodium-glucose cotransporter-2 inhibitor, dapagliflozin, reverses depressive-like behavior in a mouse model of post-traumatic stress disorder
Haneen Amawi, Tayma Makhlouf, Alaa M Hammad, et al.
Behavioural Pharmacology
|
September 29, 2025
Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice
Kentaro Matsuda, Nobue Kitanaka, Frank Scott Hall, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Journal of Pharmacological Sciences
|
February 24, 2023
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
Yuki Moriya, Yoshiyuki Kasahara, Masafumi Shimada, et al.
Metabolic Brain Disease
|
May 20, 2025
Rhoifolin as a potential anxiolytic drug for the effects of nicotine withdrawal: beneficial effects on behavior, neuroinflammation, and oxidative stress
Alaa M Hammad, Suhair Sunoqrot, Thanaa Al-Zuhd, et al.
Brain Research
|
January 24, 2012
Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice
Junichi Kitanaka, Nobue Kitanaka, F Scott Hall, et al.
Journal of Neurodevelopmental Disorders
|
October 30, 2009
A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
David Hessl, Danh V Nguyen, Cherie Green, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
Psychopharmacology
|
February 12, 2013
Impaired cliff avoidance reaction in dopamine transporter knockout mice
Motoyasu Yamashita, Yasufumi Sakakibara, F Scott Hall, et al.
Behavioural Pharmacology
|
February 22, 2014
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice
Nobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Brain Research Bulletin
|
June 3, 2025
Sodium-glucose cotransporter-2 inhibitor, dapagliflozin, reverses depressive-like behavior in a mouse model of post-traumatic stress disorder
Haneen Amawi, Tayma Makhlouf, Alaa M Hammad, et al.
Behavioural Pharmacology
|
September 29, 2025
Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice
Kentaro Matsuda, Nobue Kitanaka, Frank Scott Hall, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Journal of Pharmacological Sciences
|
February 24, 2023
Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
Yuki Moriya, Yoshiyuki Kasahara, Masafumi Shimada, et al.
Metabolic Brain Disease
|
May 20, 2025
Rhoifolin as a potential anxiolytic drug for the effects of nicotine withdrawal: beneficial effects on behavior, neuroinflammation, and oxidative stress
Alaa M Hammad, Suhair Sunoqrot, Thanaa Al-Zuhd, et al.
Brain Research
|
January 24, 2012
Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice
Junichi Kitanaka, Nobue Kitanaka, F Scott Hall, et al.
Journal of Neurodevelopmental Disorders
|
October 30, 2009
A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
David Hessl, Danh V Nguyen, Cherie Green, et al.
Page
of 17